The Journal of Organic Chemistry
Article
1.0 mL/min, λ = 254 nm) 96:4 er; 36:1 syn:anti; tR = 9.25 min (major,
syn), 10.64 min (minor, syn), 14.93 min (anti). The configuration of
the product was determined as syn by comparison with the retention
order of authentic compounds on a Chiralpak AD-H column.26
(syn)-3-Hydroxy-2-methyl-1-phenyl-3-(thiophen-2-yl)-
propan-1-one (3d). Yield 6.6 mg, 82%: 1H NMR (400 MHz, CDCl3,
δ) 7.96−7.93 (m, 2H), 7.62−7.58 (m, 1H), 7.51−7.46 (m, 2H), 7.25−
7.22 (m, 1H), 7.00−6.96 (m, 2H), 5.49 (t, J = 3.2 Hz, 1H), 3.84−3.76
(m, 1H), 3.59 (d, J = 3.2 Hz, 1H), 1.32 (d, J = 7.2 Hz, 3H); 13C NMR
(101 MHz, CDCl3, δ) 205.2, 146.0, 135.7, 133.9 (CH), 129.0 (CH),
128.7 (CH), 126.9 (CH), 124.5 (CH), 123.7 (CH), 70.7 (CH), 47.9
(CH), 12.3 (CH3); TLC Rf = 0.20 (8:1 hexanes/ethyl acetate);
HRESIMS (m/z) [M + Na]+ calcd for C14H14O2SNa, 269.0612;
found, 269.0615; HPLC (Chiralpak AD-H, isocratic 98.5:1.5 n-
heptane/2-propanol, flow rate 0.8 mL/min, λ = 254 nm) 94:6 er;
>99:1 syn:anti; tR = 56.87 min (major, syn), 71.46 min (minor, syn).
The configuration of the product was determined as syn by
δ) 204.6, 141.9, 140.3, 134.2, 130.1 (CH), 129.3 (CH), 128.5 (CH),
127.7 (CH), 126.2 (CH), 73.4 (CH), 47.4 (CH), 11.6 (CH3); TLC Rf
= 0.20 (10:1 hexanes/ethyl acetate); HRESIMS (m/z) [M + Na]+
calcd for C16H15O2ClNa, 297.0658; found, 297.0660; HPLC
(Chiralpak AD-H, isocratic 90:10 n-heptane/2-propanol, flow rate
0.8 mL/min, λ = 254 nm) 96:4 er; 15:1 syn:anti; tR = 14.59 min
(major, syn), 19.60 min (minor, syn), 18.03 min (minor, anti), 32.93
min (major, anti). The configuration of the product was determined as
syn by comparison with the 1H NMR spectra of authentic
compounds.24
(syn)-3-Hydroxy-2-methyl-3-phenyl-1-(p-tolyl)propan-1-one
1
(3l). Yield 7.4 mg, 89%: H NMR (400 MHz, CDCl3, δ) 7.87−7.84
(m, 2H), 7.43−7.34 (m, 4H), 7.29−7.25 (m, 3H), 5.25 (t, J = 2.4 Hz,
1H), 3.77 (d, J = 1.6 Hz, 1H), 3.72−3.64 (m, 1H), 2.43 (s, 3H), 1.18
(d, J = 7.2 Hz, 3H); 13C NMR (101 MHz, CDCl3, δ) 205.8, 144.8,
142.1, 133.3, 129.7 (CH), 128.9 (CH), 128.4 (CH), 127.5 (CH), 126.3
(CH), 73.2 (CH), 47.0 (CH), 21.9 (CH3), 11.3 (CH3); TLC Rf = 0.20
(10:1 hexanes/ethyl acetate); HRESIMS (m/z) [M + Na]+ calcd for
C17H18O2Na, 277.1204; found, 277.1196; HPLC (Chiralpak AD-H,
isocratic 90:10 n-heptane/2-propanol, flow rate 0.8 mL/min, λ = 254
nm) 96:4 er; 30:1 syn:anti; tR = 12.36 min (major, syn), 15.95 min
(minor, syn), 23.69 min (minor, anti), 30.30 min (major, anti). The
configuration of the product was determined as syn by comparison
22
1
comparison with the H NMR spectra of authentic compounds.
(syn)-3-Hydroxy-2-methyl-1-phenyl-3-(pyridin-2-yl)propan-
1
1-one (3e). Yield 4.3 mg, 55%: H NMR (400 MHz, CDCl3, δ) 8.56
(d, J = 4.6 Hz, 1H), 7.99−7.95 (m, 2H), 7.71−7.66 (m, 1H), 7.60−
7.55 (m, 1H), 7.52−7.44 (m, 3H), 7.20−7.16 (m, 1H), 5.24 (t, J = 4.0
Hz, 1H), 4.18 (d, J = 3.2 Hz, 1H), 4.11−4.04 (m, 1H), 1.16 (d, J = 7.2
Hz, 3H); 13C NMR (101 MHz, CDCl3, δ) 205.2, 160.8, 148.9 (CH),
136.8 (CH), 136.0, 133.6 (CH), 128.9 (CH), 128.8 (CH), 122.6
(CH), 121.5 (CH), 73.9 (CH), 46.4 (CH), 11.9 (CH3); TLC Rf = 0.20
(2:1 hexanes/ethyl acetate); HRESIMS (m/z) [M + H]+ calcd for
C15H16NO2, 242.1181; found, 242.1184; HPLC (Chiralpak AS-H,
isocratic 90:10 n-heptane/2-propanol, flow rate 0.3 mL/min, λ = 254
nm) 89:11 er; >99:1 syn:anti; tR = 30.73 min (major, syn), 44.91 min
(minor, syn). The configuration of the product was determined as syn
24
1
with the H NMR spectra of authentic compounds.
(S)-3-Hydroxy-1,3-diphenylpropan-1-one (3m). Yield 5.4 mg,
1
73%: H NMR (400 MHz, CDCl3, δ) 8.04−7.96 (m, 2H), 7.63−7.58
(m, 1H), 7.58−7.44 (m, 4H), 7.42−7.37 (m, 2H), 7.34−7.29 (m, 1H),
5.39−5.34 (m, 1H), 3.60 (d, J = 3.2 Hz, 1H), 3.39 (d, J = 5.6 Hz, 2H);
13C NMR (101 MHz, CDCl3, δ) 200.5, 143.1, 136.8, 133.9 (CH),
128.9 (CH), 128.8 (CH), 128.4 (CH), 127.9 (CH), 126.0 (CH), 70.2
(CH), 47.6 (CH2); TLC Rf = 0.20 (10:1 hexanes/ethyl acetate);
HRESIMS (m/z) [M + Na]+ calcd for C15H14O2Na, 249.0891; found,
249.0890; HPLC (Chiralcel OD−H, isocratic 90:10 hexanes/2-
propanol, flow rate 1.0 mL/min, λ = 254 nm) 68:32 er; tR = 12.47
min (S, major), 13.96 min (R, minor). The configuration of the
product was determined as S by comparison with the retention order
of authentic compounds on a Chiralcel OD−H column.38
1
by comparison with the H NMR spectra and the retention order of
authentic compounds.27
(2R,3S)-3-Hydroxy-2-methyl-1-phenylhex-4-en-1-one (3f).
Yield 4.2 mg, 63%: TLC Rf = 0.20 (10:1 hexanes/ethyl acetate);
HPLC analysis (Chiralcel OD−H, isocratic 99:1 n-heptane/2-
propanol, flow rate 0.8 mL/min, λ = 254 nm) 95:5 er; 8:1 syn:anti;
tR = 21.37 min (major, syn), 28.32 min (minor, syn), 41.35 min
(minor, anti), 44.44 min (major, anti). The configuration of the
product was determined as 2R,3S on a Chiralcel OD-H column by
comparison with the retention order of authentic compounds on a
Chiralcel OD-H column.36
(syn)-1-(4-Chlorophenyl)-3-hydroxy-2-methylnonan-1-one
1
(3n). Yield 1.8 mg, 19%: H NMR (400 MHz, CDCl3, δ) 7.91−7.87
(m, 2H), 7.48−7.45 (m, 2H), 4.05−3.99 (m, 1H), 3.45−3.37 (m, 1H),
2.94 (d, J = 3.2 Hz, 1H), 1.62−1.23 (m, 13H), 0.89 (t, J = 7.2 Hz,
3H); 13C NMR (101 MHz, CDCl3, δ) 204.8, 140.2, 134.5, 130.1
(CH), 129.3 (CH), 71.5 (CH), 44.8 (CH), 34.6 (CH2), 32.0 (CH2),
29.5 (CH2), 26.3 (CH2), 22.8 (CH2), 14.3 (CH3), 11.3 (CH3); TLC Rf
= 0.30 (10:1 hexanes/ethyl acetate); HRESIMS (m/z) [M + Na]+
calcd for C16H23O2NaCl, 305.1284; found, 305.1291; HPLC
(Chiralpak AS-H, isocratic 95:5 n-Heptane/2-propanol, flow rate 0.3
mL/min, λ = 254 nm) 97:3 er; 5:1 syn:anti; tR = 20.23 min (major,
syn), 29.75 min (minor, syn), 22.23 min (major, anti), 44.37 min
(minor, anti). The configuration of the product was determined as syn
(anti)-3-Hydroxy-2-methyl-1-phenylbutan-1-one (3g). Yield
3.2 mg, 56%: TLC Rf = 0.20 (8:1 hexanes/ethyl acetate); HPLC
(Chiralpak AS-H, isocratic 95:5 n-heptane/2-propanol, flow rate 0.6
mL/min, λ = 254 nm) 97:3 er; 3:1 anti:syn; tR = 16.10 min (major,
anti), 23.24 min (minor, anti), 19.82 min (major, syn), 37.49 min
(minor, syn). The configuration of the product was determined as anti
37
1
by comparison with the H NMR spectra of authentic compounds.
(syn)-3-Hydroxy-2-methyl-1-phenylnonan-1-one (3h). Yield
1.5 mg, 19%: TLC Rf = 0.30 (10:1 hexanes/ethyl acetate); HPLC
(Chiralpak AS-H, isocratic 95:5 n-heptane/2-propanol, flow rate 0.3
mL/min, λ = 254 nm) 97:3 er; 8:1 syn:anti; tR = 20.25 min (major,
syn), 26.87 min (minor, syn), 21.27 min (major, anti), 50.15 min
(minor, anti). The configuration of the product was determined as syn
by comparison with the retention order of authentic compounds on a
Chiralpak AS-H column.26
3
by the comparation of JHH of the syn and anti isomers (3JHH (syn) =
2.4 Hz, JHH (anti) = 7.0 Hz).39
3
3-Hydroxy-2-methyl-1-(p-tolyl)nonan-1-one (3o). Yield 1.5
1
mg, 18%: H NMR (400 MHz, CDCl3, δ) 7.86 (d, J = 8.0 Hz, 2H),
7.29 (d, J = 8.0 Hz, 2H), 4.05−4.00 (m, 1H), 3.49−3.40 (m, 1H), 2.44
(s, 3H), 1.62−1.24 (m, 13H), 0.89 (t, J = 5.6 Hz, 3H); 13C NMR (101
MHz, CDCl3, δ) 205.9, 144.6, 133.6, 129.7 (CH), 128.8 (CH), 71.5
(CH), 44.4 (CH), 34.5 (CH2), 32.0 (CH2), 29.5 (CH2), 26.3 (CH2),
22.9 (CH2), 21.9 (CH3), 14.3 (CH3), 11.3 (CH3); TLC Rf = 0.30
(10:1 hexanes/ethyl acetate); HRESIMS (m/z) [M + Na]+ calcd for
C17H26O2Na, 285.1831; found, 285.1823; HPLC (Chiralpak AS-H,
isocratic 95:5 n-Heptane/2-propanol, flow rate 0.3 mL/min, λ = 254
nm) 98:2 er; 22:1 syn:anti; tR = 19.58 min (major, syn), 30.93 min
(minor, syn), 21.87 min (major, anti), 59.31 min (minor, anti). The
configuration of the product was determined as syn by the
(anti)-3-Cyclohexyl-3-hydroxy-2-methyl-1-phenylpropan-1-
one (3i). Yield 0.8 mg, 10%: TLC Rf = 0.25 (10:1 hexanes/ethyl
acetate); HPLC (Chiralpak AS-H, isocratic 95:5 n-heptane/2-
propanol, flow rate 0.6 mL/min, λ = 254 nm) 97:3 er; 15:1 anti:syn;
tR = 12.25 min (major, anti), 21.45 min (minor, anti), 11.38 min
(major, syn), 29.02 min (minor, syn). The configuration of the product
1
was determined as anti by comparison with the H NMR spectra of
authentic compounds.21
3
comparation of JHH of the syn and anti isomers (3JHH (syn) = 2.4
(syn)-1-(4-Chlorophenyl)-3-hydroxy-2-methyl-3-phenylpro-
pan-1-one (3k). Yield 8.1 mg, 90%: 1H NMR (400 MHz, CDCl3, δ)
7.88−7.85 (m, 2H), 7.46−7.44 (m, 2H), 7.41−7.33 (m, 4H), 7.30−
7.25 (m, 1H), 5.23 (t, J = 2.4 Hz, 1H), 3.69−3.62 (m, 1H), 3.48 (d, J =
2.4 Hz, 1H), 1.21 (d, J = 7.6 Hz, 3H); 13C NMR (101 MHz, CDCl3,
Hz, JHH (anti) = 6.4 Hz).39
3
(syn)-1-(4-Chlorophenyl)-1-hydroxy-2-methylpentan-3-one
1
(3r). Yield 2.5 mg, 39%: H NMR (400 MHz, CDCl3, δ) 7.34−7.30
(m, 2H), 7.29−2.25 (m, 2H), 5.08 (d, J = 3.2 Hz, 1H), 3.25 (brs, 1H),
5630
dx.doi.org/10.1021/jo300800b | J. Org. Chem. 2012, 77, 5624−5632